Who and when to vaccinate against influenza.
Children
Chronic disease
Influenza
Older adults
Pregnant women
Risk groups
Vaccine
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
18
12
2019
revised:
19
02
2020
accepted:
19
02
2020
pubmed:
29
2
2020
medline:
25
7
2020
entrez:
29
2
2020
Statut:
ppublish
Résumé
Known since Hippocrates and of continuing public health importance, influenza remains a major cause of morbidity and mortality worldwide, and large segments of the human population are affected every year. Vaccination is the most effective means of preventing influenza infection. Today, many countries have implemented annual influenza vaccination programs, and there is increasing awareness of the potential societal and health benefits of vaccinating pregnant women, children aged 6 months to 5 years, older adults, and persons with underlying medical conditions that make them vulnerable to serious complications of influenza. In this non-systematic review, we summarize data on influenza epidemiology and influenza vaccine immunogenicity, efficacy/effectiveness, and safety in the main high-risk groups. We also discuss the optimal time to vaccinate and the effect of pre-existing immunity on vaccine response.
Identifiants
pubmed: 32109627
pii: S1201-9712(20)30098-9
doi: 10.1016/j.ijid.2020.02.040
pii:
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
375-387Informations de copyright
Copyright © 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.. All rights reserved.